Twenty-nine of 33 sera from children experiencing a silent dengue infection neutralized dengue 2 in human monocyte cultures; 6 of 7 sera from children experiencing overt disease enhanced or failed to neutralize dengue 2 virus. Children with high levels of heterotypic neutralizing antibodies were protected from severe disease accompanying secondary dengue infections. Heterotypic antibodies provide partial, not complete protection.